Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Mattick

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Preventive Medicine|December 15, 2015
Associations between behavioural risk factors and smoking, heavy smoking and future smoking among an Australian population-based sampleJaimi M Iredale, Philip J Clare, Ryan J Courtney, et al.
Alcoholism, Clinical and Experimental Research|August 7, 2015
Early Adolescent Alcohol Use: Are Sipping and Drinking Distinct?Monika Wadolowski, Delyse Hutchinson, Raimondo Bruno, et al.
The Medical Journal of Australia|August 4, 2009
Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationLouisa Degenhardt, Briony K Larance, James R Bell, et al.
The Australian and New Zealand Journal of Psychiatry|February 23, 2018
Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depressionBreanne Hobden, Jamie Bryant, Mariko Carey, et al.
BMJ Open|August 8, 2018
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) StudySarah Larney, Matthew Hickman, David A Fiellin, et al.
Alcoholism, Clinical and Experimental Research|February 17, 2015
Sipping, drinking, and early adolescent alcohol consumption: a cautionary noteMonika Wadolowski, Raimondo Bruno, Alexandra Aiken, et al.
Addiction (Abingdon, England)|January 20, 2009
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependenceJames Shearer, Shane Darke, Craig Rodgers, et al.
Drug and Alcohol Dependence|June 25, 2003
Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductionsCourtney L Breen, Simon J Harris, Nicholas Lintzeris, et al.
Nutrients|March 10, 2018
Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort StudyAmy Peacock, Delyse Hutchinson, Judy Wilson, et al.
Addiction (Abingdon, England)|May 9, 2012
Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)Rebecca McKetin, Jake M Najman, Amanda L Baker, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Preventive Medicine|December 15, 2015
Associations between behavioural risk factors and smoking, heavy smoking and future smoking among an Australian population-based sampleJaimi M Iredale, Philip J Clare, Ryan J Courtney, et al.
Alcoholism, Clinical and Experimental Research|August 7, 2015
Early Adolescent Alcohol Use: Are Sipping and Drinking Distinct?Monika Wadolowski, Delyse Hutchinson, Raimondo Bruno, et al.
The Medical Journal of Australia|August 4, 2009
Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationLouisa Degenhardt, Briony K Larance, James R Bell, et al.
The Australian and New Zealand Journal of Psychiatry|February 23, 2018
Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depressionBreanne Hobden, Jamie Bryant, Mariko Carey, et al.
BMJ Open|August 8, 2018
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) StudySarah Larney, Matthew Hickman, David A Fiellin, et al.
Alcoholism, Clinical and Experimental Research|February 17, 2015
Sipping, drinking, and early adolescent alcohol consumption: a cautionary noteMonika Wadolowski, Raimondo Bruno, Alexandra Aiken, et al.
Addiction (Abingdon, England)|January 20, 2009
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependenceJames Shearer, Shane Darke, Craig Rodgers, et al.
Drug and Alcohol Dependence|June 25, 2003
Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductionsCourtney L Breen, Simon J Harris, Nicholas Lintzeris, et al.
Nutrients|March 10, 2018
Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort StudyAmy Peacock, Delyse Hutchinson, Judy Wilson, et al.
Addiction (Abingdon, England)|May 9, 2012
Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)Rebecca McKetin, Jake M Najman, Amanda L Baker, et al.
Pageof 16